Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference
Clover Health (NASDAQ:CLOV) announced that CFO Peter Kuipers will present at the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025, at 11:00 a.m. Eastern Time.
Investors can access both the live webcast and replay of the presentation through Clover Health's investor relations website at investors.cloverhealth.com.
Clover Health (NASDAQ:CLOV) ha annunciato che il CFO Peter Kuipers sarà relatore al 45° Annual Growth Conference di Canaccord Genuity il 12 agosto 2025 alle 11:00 ora della costa orientale.
Gli investitori potranno seguire la presentazione in diretta streaming e rivederla successivamente tramite il sito web delle relazioni con gli investitori di Clover Health all'indirizzo investors.cloverhealth.com.
Clover Health (NASDAQ:CLOV) anunció que el CFO Peter Kuipers presentará en la 45ª Conferencia Anual de Crecimiento de Canaccord Genuity el 12 de agosto de 2025 a las 11:00 a.m. hora del Este.
Los inversores podrán acceder tanto a la transmisión en vivo como a la repetición de la presentación a través del sitio web de relaciones con inversores de Clover Health en investors.cloverhealth.com.
Clover Health (NASDAQ:CLOV)는 CFO Peter Kuipers가 2025년 8월 12일 동부 표준시 오전 11시에 개최되는 Canaccord Genuity 제45회 연례 성장 컨퍼런스에서 발표할 예정임을 발표했습니다.
투자자들은 Clover Health의 투자자 관계 웹사이트 investors.cloverhealth.com을 통해 발표의 라이브 웹캐스트와 재방송을 모두 시청할 수 있습니다.
Clover Health (NASDAQ:CLOV) a annoncé que le CFO Peter Kuipers présentera lors de la 45e conférence annuelle de croissance Canaccord Genuity le 12 août 2025 à 11h00, heure de l'Est.
Les investisseurs pourront accéder à la fois au webdiffusion en direct et au replay de la présentation via le site des relations investisseurs de Clover Health à l'adresse investors.cloverhealth.com.
Clover Health (NASDAQ:CLOV) gab bekannt, dass CFO Peter Kuipers am 45. jährlichen Wachstumskonferenz von Canaccord Genuity am 12. August 2025 um 11:00 Uhr Eastern Time präsentieren wird.
Investoren können sowohl den Live-Webcast als auch die Wiederholung der Präsentation über die Investor-Relations-Website von Clover Health unter investors.cloverhealth.com abrufen.
- None.
- None.
WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 11:00 a.m. Eastern Time.
A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence and Congestive Heart Failure, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Investor Relations:
Ryan Schmidt
investors@cloverhealth.com
Press Inquiries:
press@cloverhealth.com
